Adaptive Biotechnologies ADPT Interest Expense
Discontinued — last reported Q1 '26
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:InterestExpense.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's interest expense?
- Adaptive Biotechnologies (ADPT) reported interest expense of $2.89M in Q1 2026.
- How has Adaptive Biotechnologies's interest expense changed year-over-year?
- Adaptive Biotechnologies's interest expense decreased by 0.6% year-over-year, from $2.91M to $2.89M.
- What is the long-term trend for Adaptive Biotechnologies's interest expense?
- Over 2 years (2023 to 2025), Adaptive Biotechnologies's interest expense has grown at a -7.6% compound annual growth rate (CAGR), from $13.8M to $11.78M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.